Northwest Biotherapeutics and the UK National Health Service Blood and Transplant Announce Collaboration to Support DCVax®-L Production
Northwest Biotherapeutics and UK NHS Blood and Transplant announced a collaboration supporting production of DCVax-L, with NHSBT performing leukapheresis and specialist cell processing. The model launches in Leeds and Oxford, and the parties are exploring phased expansion to additional NHSBT locations across England alongside broader lab collaboration.
Key figures
- Initial locations
- ["Leeds","Oxford"]
- Phase3 trial patients
- 331
- Dcvax direct phase1 patients
- 40
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.